News Industry News CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019 September 25, 2019
News Industry News FDA approves Bayer's Gadavist® (gadobutrol) injection as first contrast agent for use with magnetic resonance angiography of supra-aortic arteries May 02, 2016
News Industry News Guerbet receives FDA 510k clearance for the OptiOne™ Single-Head Contrast Delivery System February 10, 2016
News Industry News Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy November 08, 2011